Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Risk Reports
Published in: Current Cardiovascular Risk Reports 6/2010

01-11-2010 | Clinical Trial Report

Assessment of the JUPITER Trial

Authors: Daniel E. Forman, J. Michael Gaziano

Published in: Current Cardiovascular Risk Reports | Issue 6/2010

Login to get access

Excerpt

Ridker PM, Danielson E, Fonseca FA, et al; JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195–2207. …
Literature
1.
Ridker PM, Danielson E, Fonseca FA, et al; JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195–2207.CrossRefPubMed
2.
Glynn RJ, Koenig W, Nordestgaard BG, et al.: Rosuvastatin for primary prevention in older persons with elevated c-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med 2010, 152:488–496.PubMed
3.
Ridker PM, Paynter NP, Rifai N, et al.: C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 2008, 118:2243–2251.CrossRefPubMed
4.
Foody JM, Krumholz HM: Are statins indicated for the primary prevention of CAD in octogenarians? antagonist viewpoint. Am J Geriatr Cardiol 2003, 12:357–360.CrossRefPubMed
5.
Kaul S, Morrissey RP, Diamond GA: By Jove! What is a clinician to make of JUPITER? Arch Intern Med 2010, 170:1073–1077.CrossRefPubMed
6.
Heart Protection Study Collaborative Group: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial. BMC Med 2005, 3:6.
7.
Wang TJ, Gona P, Larson MG, et al.: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631–2639.CrossRefPubMed
8.
Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 2003, 107:139–146.CrossRefPubMed
Metadata
Title
Assessment of the JUPITER Trial
Authors
Daniel E. Forman
J. Michael Gaziano
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Cardiovascular Risk Reports / Issue 6/2010
Print ISSN: 1932-9520
Electronic ISSN: 1932-9563
DOI
https://doi.org/10.1007/s12170-010-0126-4

Other articles of this Issue 6/2010

Current Cardiovascular Risk Reports 6/2010 Go to the issue

ReviewPaper

Genetic Basis of Ventricular Arrhythmias

ReviewPaper

The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome

ReviewPaper

Smoking as a Chronic Disease

ReviewPaper

Smoking and Smoking Cessation During Pregnancy and Postpartum

ReviewPaper

Type 2 Diabetes and Genetics, 2010: Translating Knowledge into Understanding

ReviewPaper

Clinical Implications of Lipid Genetics for Cardiovascular Disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits